Pfizer critical of generic plan for three million statin patients

November 30, 2005

More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …

Pfizer’s new anti-smoking drug shows promise

November 29, 2005
Sales and Marketing

Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …

Pharma unprepared for shift to secondary care

November 28, 2005
Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …

AstraZeneca fights generic Nexium bid

November 25, 2005
Sales and Marketing

AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …

Which company has the industry’s best R&D pipeline?

November 25, 2005
Sales and Marketing

Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …

Chiron to make up shortfall in UK flu vaccine

November 25, 2005
Manufacturing and Production

Chiron has agreed to help the UK government make up a shortfall in flu vaccine supplies by producing an extra …

PR as important as salesforces, say marketers

November 24, 2005
Medical Communications

A new survey of the UK pharmaceutical industry has found PR is considered just as important to marketing efforts as …

FDA clears Tamiflu in children after safety scare

November 22, 2005
Sales and Marketing

The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …

Amgen sues Roche over new anaemia treatment

November 22, 2005
Sales and Marketing

Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …

New antibody could be COPD breakthrough, say companies

November 21, 2005
Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …

Asthma drug warning hits GlaxoSmithKline

November 21, 2005
Sales and Marketing

Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …

Oxford and GSK to collaborate on cancer research in India

November 18, 2005
Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …

Which company is pharma’s rising star?

November 17, 2005
Sales and Marketing

Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …

Patient demand brings Sativex to UK ahead of approval

November 17, 2005
Sales and Marketing GW Pharmaceuticals, Sativex

The unlicensed cannabis-based medicine Sativex will be available in the UK to treat neuropathic pain on a named patient basis …

Haringey spawns new NHS collaboration for Pfizer

November 17, 2005

Pfizer's high profile disease management project with Haringey Teaching PCT looks set to be declared a success – and has …

De Facto expands into med ed

November 17, 2005
Medical Communications

PR firm De Facto has launched a medical education arm and signed up its first two clients for the new …

Stricter new UK industry code of practice launched

November 16, 2005
Medical Communications, Sales and Marketing

The UK pharmaceutical industry is to adopt a new stricter code of conduct to help distance itself from allegations of …

Study results not IDEAL for Lipitor

November 16, 2005
Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …

Complete prescribing power proposed for nurses and pharmacists

November 15, 2005

Some nurses and pharmacists could soon be able to prescribe almost any drug available on the NHS under sweeping changes …

Government should stay out of NHS medicines decisions, says ABPI

November 15, 2005

The ABPI has indicated its discomfort with government interference in NHS decision-making on medicines following the intervention of Patricia Hewitt …

The Gateway to Local Adoption Series

Latest content